Search...
/
The Fly Cast
Press play to listen
Competitive Advantages
Global Integrated CDMO Services: Lonza offers unparalleled end-to-end development and manufacturing capabilities, spanning biologics, small molecules, and advanced therapies, allowing clients to consolidate their outsourcing needs with a single, reliable partner.
Leadership in Advanced Therapies: Lonza is a pioneer and market leader in the complex and high-growth areas of cell and gene therapy manufacturing, providing highly specialized expertise and state-of-the-art facilities that few competitors can match.
Robust Quality & Regulatory Compliance: With a sterling track record of navigating stringent global regulatory requirements and maintaining high-quality manufacturing standards, Lonza instills critical trust and reduces risk for its pharmaceutical clients.
Risks
Regulatory Compliance Risk: Failure to adhere to stringent global pharmaceutical and biotech regulations can lead to production stoppages, fines, and reputational damage.
Competitive Landscape Risk: Operating in a highly competitive contract development and manufacturing organization (CDMO) market may lead to pricing pressure and reduced market share.
Client Concentration Risk: Significant reliance on a few key clients or the success of specific drug programs could result in revenue volatility if contracts are lost or programs are terminated.
Today
10:23 AM
Over a week ago
Jun 25, 1:38 PM
Jun 3, 5:26 AM
May 18, 12:48 PM
Apr 15, 1:32 PM
Feb 11, 10:03 AM
Feb 11, 9:59 AM
Feb 2, 1:38 PM
Nov 25, 4:25 AM
Oct 29, 3:22 PM
Jul 28, 2:52 PM
Jul 24, 2:25 PM
No more stories